M&T Bank’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-58,170
Closed -$2.1M 1673
2024
Q4
$2.1M Buy
58,170
+6,335
+12% +$214K 0.01% 657
2024
Q3
$2.2M Buy
51,835
+858
+2% +$36.4K 0.01% 650
2024
Q2
$2.05M Sell
50,977
-4,318
-8% -$180K 0.01% 645
2024
Q1
$1.96M Buy
55,295
+5,646
+11% +$151K 0.01% 667
2023
Q4
$1.47M Buy
49,649
+26,943
+119% +$559K 0.01% 745
2023
Q3
$472K Buy
+22,706
New +$624K ﹤0.01% 1111
2022
Q2
Sell
-1,995
Closed -$233K 1701
2022
Q1
$233K Hold
1,995
﹤0.01% 1325
2021
Q4
$301K Buy
+1,995
New +$269K ﹤0.01% 1248
2021
Q1
Sell
-5,292
Closed -$506K 1710
2020
Q4
$506K Sell
5,292
-1,377
-21% -$142K ﹤0.01% 1049
2020
Q3
$757K Buy
6,669
+537
+9% +$56.4K ﹤0.01% 808
2020
Q2
$606K Sell
6,132
-1,396
-19% -$111K ﹤0.01% 868
2020
Q1
$485K Buy
+7,528
New +$527K ﹤0.01% 919

Other funds holding TNDM

M&T Bank's TNDM Position: Q1 2025 in Review

M&T Bank sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 58,170 shares — an estimated $2.1M sold.

M&T Bank first reported a position in TNDM in Q1 2020 and held it in 12 quarters. The position peaked at $2.2M in Q3 2024. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • M&T Bank reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • M&T Bank sold 58,170 Tandem Diabetes Care shares in Q1 2025, an estimated $2.1M.
  • M&T Bank first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 12 quarters.
  • M&T Bank's Tandem Diabetes Care position peaked at $2.2M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on M&T Bank's 13F filing for Q1 2025, filed 30 Apr 2025.